オーファンドラッグ（希少疾病用医薬品）市場は、2023年から2028年の間に1,461億米ドル成長すると予測されており、予測期間中にCAGRは11.62%で加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、堅調なパイプラインと最近の医薬品承認、希少疾病の発生率の増加、希少疾病用医薬品の開発に対するインセンティブの利用可能性によって牽引されています。
この調査では、今後数年間のオーファンドラッグ市場の成長を促進する主な理由の 1 つとして、提携、パートナーシップ、合併と買収に戦略的に重点を置いていることが特定されています。また、併用療法や新規標的の出現、遺伝子検査やタンパク質バイオマーカーの需要の高まりにより、市場での需要が大幅に増加すると予想されます。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Orphan Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Orphan Drugs Market 2018 - 2022 ($ billion)
4.2 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.3 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
6.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
6.3 Hospital Pharmacy - Market size and forecast 2023-2028
Chart on Hospital Pharmacy - Market size and forecast 2023-2028 ($ billion)
Data Table on Hospital Pharmacy - Market size and forecast 2023-2028 ($ billion)
Chart on Hospital Pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Hospital Pharmacy - Year-over-year growth 2023-2028 (%)
6.4 Specialty pharmacy - Market size and forecast 2023-2028
Chart on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
Data Table on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
Chart on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
6.5 Retail pharmacy - Market size and forecast 2023-2028
Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ billion)
Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Product
7.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
7.3 Biologics - Market size and forecast 2023-2028
Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
Chart on Biologics - Year-over-year growth 2023-2028 (%)
Data Table on Biologics - Year-over-year growth 2023-2028 (%)
7.4 Non-biologics - Market size and forecast 2023-2028
Chart on Non-biologics - Market size and forecast 2023-2028 ($ billion)
Data Table on Non-biologics - Market size and forecast 2023-2028 ($ billion)
Chart on Non-biologics - Year-over-year growth 2023-2028 (%)
Data Table on Non-biologics - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Market opportunity by Product ($ billion)
Data Table on Market opportunity by Product ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals Inc. - Overview
Alnylam Pharmaceuticals Inc. - Product / Service
Alnylam Pharmaceuticals Inc. - Key news
Alnylam Pharmaceuticals Inc. - Key offerings
12.5 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
12.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.7 bluebird bio Inc.
bluebird bio Inc. - Overview
bluebird bio Inc. - Product / Service
bluebird bio Inc. - Key offerings
12.8 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.9 CSL Ltd.
CSL Ltd. - Overview
CSL Ltd. - Business segments
CSL Ltd. - Key news
CSL Ltd. - Key offerings
CSL Ltd. - Segment focus
12.10 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.11 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.12 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.13 Ipsen Pharma
Ipsen Pharma - Overview
Ipsen Pharma - Business segments
Ipsen Pharma - Key offerings
Ipsen Pharma - Segment focus
12.14 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.15 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.16 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.17 Ractigen Therapeutics
Ractigen Therapeutics - Overview
Ractigen Therapeutics - Product / Service
Ractigen Therapeutics - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Orphan Drugs Market 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits33: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Distribution Channel
Exhibits35: Data Table on Comparison by Distribution Channel
Exhibits36: Chart on Hospital Pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits37: Data Table on Hospital Pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Chart on Hospital Pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Hospital Pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on Specialty pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Specialty pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits45: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits52: Market opportunity by Distribution Channel ($ billion)
Exhibits53: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits54: Chart on Product - Market share 2023-2028 (%)
Exhibits55: Data Table on Product - Market share 2023-2028 (%)
Exhibits56: Chart on Comparison by Product
Exhibits57: Data Table on Comparison by Product
Exhibits58: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits60: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Non-biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on Non-biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on Non-biologics - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Non-biologics - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by Product ($ billion)
Exhibits67: Data Table on Market opportunity by Product ($ billion)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ billion)
Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: AbbVie Inc. - Overview
Exhibits118: AbbVie Inc. - Product / Service
Exhibits119: AbbVie Inc. - Key news
Exhibits120: AbbVie Inc. - Key offerings
Exhibits121: Alnylam Pharmaceuticals Inc. - Overview
Exhibits122: Alnylam Pharmaceuticals Inc. - Product / Service
Exhibits123: Alnylam Pharmaceuticals Inc. - Key news
Exhibits124: Alnylam Pharmaceuticals Inc. - Key offerings
Exhibits125: Astellas Pharma Inc. - Overview
Exhibits126: Astellas Pharma Inc. - Product / Service
Exhibits127: Astellas Pharma Inc. - Key news
Exhibits128: Astellas Pharma Inc. - Key offerings
Exhibits129: AstraZeneca Plc - Overview
Exhibits130: AstraZeneca Plc - Product / Service
Exhibits131: AstraZeneca Plc - Key news
Exhibits132: AstraZeneca Plc - Key offerings
Exhibits133: bluebird bio Inc. - Overview
Exhibits134: bluebird bio Inc. - Product / Service
Exhibits135: bluebird bio Inc. - Key offerings
Exhibits136: Bristol Myers Squibb Co. - Overview
Exhibits137: Bristol Myers Squibb Co. - Product / Service
Exhibits138: Bristol Myers Squibb Co. - Key news
Exhibits139: Bristol Myers Squibb Co. - Key offerings
Exhibits140: CSL Ltd. - Overview
Exhibits141: CSL Ltd. - Business segments
Exhibits142: CSL Ltd. - Key news
Exhibits143: CSL Ltd. - Key offerings
Exhibits144: CSL Ltd. - Segment focus
Exhibits145: F. Hoffmann La Roche Ltd. - Overview
Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
Exhibits147: F. Hoffmann La Roche Ltd. - Key news
Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits150: Gilead Sciences Inc. - Overview
Exhibits151: Gilead Sciences Inc. - Product / Service
Exhibits152: Gilead Sciences Inc. - Key news
Exhibits153: Gilead Sciences Inc. - Key offerings
Exhibits154: GlaxoSmithKline Plc - Overview
Exhibits155: GlaxoSmithKline Plc - Business segments
Exhibits156: GlaxoSmithKline Plc - Key news
Exhibits157: GlaxoSmithKline Plc - Key offerings
Exhibits158: GlaxoSmithKline Plc - Segment focus
Exhibits159: Ipsen Pharma - Overview
Exhibits160: Ipsen Pharma - Business segments
Exhibits161: Ipsen Pharma - Key offerings
Exhibits162: Ipsen Pharma - Segment focus
Exhibits163: Johnson and Johnson Services Inc. - Overview
Exhibits164: Johnson and Johnson Services Inc. - Business segments
Exhibits165: Johnson and Johnson Services Inc. - Key news
Exhibits166: Johnson and Johnson Services Inc. - Key offerings
Exhibits167: Johnson and Johnson Services Inc. - Segment focus
Exhibits168: Merck and Co. Inc. - Overview
Exhibits169: Merck and Co. Inc. - Business segments
Exhibits170: Merck and Co. Inc. - Key news
Exhibits171: Merck and Co. Inc. - Key offerings
Exhibits172: Merck and Co. Inc. - Segment focus
Exhibits173: Novartis AG - Overview
Exhibits174: Novartis AG - Business segments
Exhibits175: Novartis AG - Key news
Exhibits176: Novartis AG - Key offerings
Exhibits177: Novartis AG - Segment focus
Exhibits178: Ractigen Therapeutics - Overview
Exhibits179: Ractigen Therapeutics - Product / Service
Exhibits180: Ractigen Therapeutics - Key offerings
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Information sources
Exhibits186: Data validation
Exhibits187: Validation techniques employed for market sizing
Exhibits188: Data synthesis
Exhibits189: 360 degree market analysis
Exhibits190: List of abbreviations
